$CSTAF
Constellation Acquisition Corp I

2023 Q2 Form 10-Q Financial Statement

#000121390023067775 Filed on August 15, 2023

View on sec.gov

Income Statement

Concept 2023 Q2 2022 Q4
Revenue $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $311.7K $238.7K
YoY Change -13.22% -13.27%
Operating Profit -$311.7K
YoY Change -13.22%
Interest Expense $536.5K $2.623M
YoY Change 132.22% 43037.01%
% of Operating Profit
Other Income/Expense, Net $1.098M $243.3K
YoY Change -66.09% -66.45%
Pretax Income $786.5K $2.627M
YoY Change -72.69% 475.98%
Income Tax
% Of Pretax Income
Net Earnings $786.5K $2.627M
YoY Change -72.69% 475.98%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share $0.06 $0.07
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding

Balance Sheet

Concept 2023 Q2 2022 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $3.240K $37.74K
YoY Change -97.81% -83.11%
Cash & Equivalents $3.236K $37.74K
Short-Term Investments
Other Short-Term Assets $281.4K $33.45K
YoY Change -0.1% -91.74%
Inventory
Prepaid Expenses $281.4K $33.45K
Receivables
Other Receivables
Total Short-Term Assets $284.6K $71.20K
YoY Change -33.72% -88.66%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $47.84M $314.5M
YoY Change -84.58% 1.44%
Other Assets $0.00
YoY Change -100.0%
Total Long-Term Assets $47.84M $314.5M
YoY Change -84.58% 1.43%
TOTAL ASSETS
Total Short-Term Assets $284.6K $71.20K
Total Long-Term Assets $47.84M $314.5M
Total Assets $48.12M $314.6M
YoY Change -84.51% 1.25%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $60.00K
YoY Change
Accrued Expenses $1.821M $974.0K
YoY Change 114.98% 37.3%
Deferred Revenue
YoY Change
Short-Term Debt $2.092M $258.8K
YoY Change 817.84%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $3.973M $1.233M
YoY Change 269.62% 73.78%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $11.78M $11.32M
YoY Change -9.98% -45.64%
Total Long-Term Liabilities $11.78M $11.32M
YoY Change -9.98% -45.64%
TOTAL LIABILITIES
Total Short-Term Liabilities $3.973M $1.233M
Total Long-Term Liabilities $11.78M $11.32M
Total Liabilities $15.75M $12.56M
YoY Change 11.25% -41.71%
SHAREHOLDERS EQUITY
Retained Earnings -$15.47M -$12.49M
YoY Change 12.65% -40.1%
Common Stock $1.823M $1.162M
YoY Change 182.48%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$15.47M -$12.49M
YoY Change
Total Liabilities & Shareholders Equity $48.12M $314.6M
YoY Change -84.51% 1.25%

Cashflow Statement

Concept 2023 Q2 2022 Q4
OPERATING ACTIVITIES
Net Income $786.5K $2.627M
YoY Change -72.69% 475.98%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$87.63K -$80.83K
YoY Change -50.92% -68.97%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities -$450.0K $0.00
YoY Change
Cash From Investing Activities -$450.0K $0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 535.0K 0.000
YoY Change 134.7%
NET CHANGE
Cash From Operating Activities -87.63K -80.83K
Cash From Investing Activities -450.0K 0.000
Cash From Financing Activities 535.0K 0.000
Net Change In Cash -2.630K -80.83K
YoY Change -105.32% -68.97%
FREE CASH FLOW
Cash From Operating Activities -$87.63K -$80.83K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-06-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
dei Document Transition Report
DocumentTransitionReport
false
dei Entity Registrant Name
EntityRegistrantName
CONSTELLATION ACQUISITION CORP I
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
E9
dei Entity File Number
EntityFileNumber
001-39945
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
98-1574835
dei Entity Address Address Line1
EntityAddressAddressLine1
200 Park Ave
dei Entity Address Address Line2
EntityAddressAddressLine2
32nd Floor
dei Entity Address City Or Town
EntityAddressCityOrTown
New York
dei Entity Address State Or Province
EntityAddressStateOrProvince
NY
dei City Area Code
CityAreaCode
(914)
dei Local Phone Number
LocalPhoneNumber
615-9912
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
true
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3236 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
37743 usd
CY2023Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
281380 usd
CY2022Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
33454 usd
CY2023Q2 us-gaap Assets Current
AssetsCurrent
284616 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
71197 usd
CY2023Q2 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
47837943 usd
CY2022Q4 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
314517268 usd
CY2023Q2 us-gaap Assets
Assets
48122559 usd
CY2022Q4 us-gaap Assets
Assets
314588465 usd
CY2023Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1820826 usd
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
973996 usd
CY2023Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
60000 usd
CY2023Q2 us-gaap Notes Payable Current
NotesPayableCurrent
227208 usd
CY2022Q4 us-gaap Notes Payable Current
NotesPayableCurrent
258780 usd
CY2023Q2 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
1865000 usd
CY2023Q2 us-gaap Liabilities Current
LiabilitiesCurrent
3973034 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1232776 usd
CY2023Q2 csta Deferred Underwriting Fees
DeferredUnderwritingFees
10850000 usd
CY2022Q4 csta Deferred Underwriting Fees
DeferredUnderwritingFees
10850000 usd
CY2023Q2 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
926670 usd
CY2022Q4 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
474000 usd
CY2023Q2 us-gaap Liabilities
Liabilities
15749704 usd
CY2022Q4 us-gaap Liabilities
Liabilities
12556776 usd
CY2023Q2 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
47837943 usd
CY2022Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
314517268 usd
CY2023Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2023Q2 csta Common Stock Value1
CommonStockValue1
775 usd
CY2022Q4 csta Common Stock Value1
CommonStockValue1
775 usd
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-15465863 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-12486354 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-15465088 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-12485579 usd
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
48122559 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
314588465 usd
CY2023Q2 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
311735 usd
CY2022Q2 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
359218 usd
us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
1626839 usd
us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
590613 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-311735 usd
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-359218 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-1626839 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-590613 usd
CY2023Q2 us-gaap Interest Income Securities Us Treasury
InterestIncomeSecuritiesUSTreasury
536515 usd
CY2022Q2 us-gaap Interest Income Securities Us Treasury
InterestIncomeSecuritiesUSTreasury
231038 usd
us-gaap Interest Income Securities Us Treasury
InterestIncomeSecuritiesUSTreasury
1906421 usd
us-gaap Interest Income Securities Us Treasury
InterestIncomeSecuritiesUSTreasury
235370 usd
CY2023Q2 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-561690 usd
CY2022Q2 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-3007632 usd
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
452670 usd
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-7751030 usd
CY2023Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1098205 usd
CY2022Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
3238670 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1453751 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
7986400 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
786470 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
2879452 usd
us-gaap Net Income Loss
NetIncomeLoss
-173088 usd
us-gaap Net Income Loss
NetIncomeLoss
7395787 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-12485579 usd
CY2023Q1 us-gaap Stock Redeemed Or Called During Period Value
StockRedeemedOrCalledDuringPeriodValue
-1819906 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-959558 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-15265043 usd
CY2023Q2 us-gaap Stock Redeemed Or Called During Period Value
StockRedeemedOrCalledDuringPeriodValue
-986515 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
786470 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-15465088 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-20844590 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
4516335 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-16328255 usd
CY2022Q2 us-gaap Stock Redeemed Or Called During Period Value
StockRedeemedOrCalledDuringPeriodValue
-278958 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
2879452 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-13727761 usd
us-gaap Net Income Loss
NetIncomeLoss
-173088 usd
us-gaap Net Income Loss
NetIncomeLoss
7395787 usd
us-gaap Interest Income Securities Us Treasury
InterestIncomeSecuritiesUSTreasury
1906421 usd
us-gaap Interest Income Securities Us Treasury
InterestIncomeSecuritiesUSTreasury
235370 usd
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
452670 usd
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-7751030 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
247926 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-123065 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
846830 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
137571 usd
us-gaap Increase Decrease In Due To Related Parties Current
IncreaseDecreaseInDueToRelatedPartiesCurrent
60000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-26396 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-967935 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-303581 usd
us-gaap Payments To Invest In Decommissioning Fund
PaymentsToInvestInDecommissioningFund
900000 usd
csta Cash Withdrawn From Trust Account In Connection With Redemption
CashWithdrawnFromTrustAccountInConnectionWithRedemption
-269485746 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
268585746 usd
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
31572 usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
227945 usd
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
1865000 usd
us-gaap Payments For Repurchase Of Other Equity
PaymentsForRepurchaseOfOtherEquity
269485746 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-267652318 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
227945 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-34507 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-75636 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
37743 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
223378 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3236 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
147742 usd
CY2021Q1 csta Gross Proceeds
GrossProceeds
310000000 usd
CY2023Q2 csta Private Placement Warrant
PrivatePlacementWarrant
1.5
csta Gross Proceeds
GrossProceeds
8200000 usd
CY2023Q2 us-gaap Business Acquisition Cost Of Acquired Entity Transaction Costs
BusinessAcquisitionCostOfAcquiredEntityTransactionCosts
17586741 usd
us-gaap Other Underwriting Expense
OtherUnderwritingExpense
6200000 usd
CY2023Q2 us-gaap Financing Receivable Deferred Income
FinancingReceivableDeferredIncome
10850000 usd
CY2023Q2 us-gaap Other Ownership Interests Offering Costs
OtherOwnershipInterestsOfferingCosts
536741 usd
CY2021Q1 csta Net Offering Proceeds
NetOfferingProceeds
310000000 usd
CY2021Q1 csta Sale Of Stock Issue Price Per Share
SaleOfStockIssuePricePerShare
10
CY2021Q1 us-gaap Maturity Of Time Deposits
MaturityOfTimeDeposits
P185D
CY2021Q1 csta Percentage Of Public Shareholding To Be Redeemed In Case Business Combination Is Not Consummated
PercentageOfPublicShareholdingToBeRedeemedInCaseBusinessCombinationIsNotConsummated
1 pure
csta Shares Issued Price Per Share1
SharesIssuedPricePerShare1
10
CY2023Q2 us-gaap Liquidation Basis Of Accounting Accrued Costs To Dispose Of Assets And Liabilities
LiquidationBasisOfAccountingAccruedCostsToDisposeOfAssetsAndLiabilities
100000 usd
CY2023Q2 csta Per Share Amount To Be Maintained In The Trust Account
PerShareAmountToBeMaintainedInTheTrustAccount
10 shares
CY2023Q1 us-gaap Loans Payable
LoansPayable
150000 usd
CY2023Q2 csta Redemption Price Per Share
RedemptionPricePerShare
10.167
CY2023Q2 us-gaap Temporary Equity Aggregate Amount Of Redemption Requirement
TemporaryEquityAggregateAmountOfRedemptionRequirement
269485746 usd
CY2023Q2 us-gaap Notes Issued1
NotesIssued1
150000 usd
CY2023Q2 us-gaap Common Stock Held In Trust
CommonStockHeldInTrust
150000 usd
CY2023Q2 us-gaap Common Stock Held In Trust
CommonStockHeldInTrust
150000 usd
CY2023Q3 us-gaap Common Stock Held In Trust
CommonStockHeldInTrust
150000 usd
CY2023Q2 csta Operating Bank Account
OperatingBankAccount
3236 usd
CY2023Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1823418 usd
CY2023Q2 us-gaap Temporary Equity Shares Issued
TemporaryEquitySharesIssued
4493843 shares
CY2022Q4 us-gaap Temporary Equity Shares Issued
TemporaryEquitySharesIssued
31000000 shares
CY2022 csta Gross Proceed
GrossProceed
310000000 usd
CY2022 us-gaap Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
20150000 usd
us-gaap Use Of Estimates
UseOfEstimates
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Use of Estimates</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of unaudited condensed financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited condensed financial statements and the reported amounts of expenses during the reporting period. Accordingly, actual results could differ from those estimates.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. One of the more significant accounting estimates included in these financial statements is the determination of the fair value of the warrant liability and convertible promissory notes. Such estimates may be subject to change as more current information becomes available and, accordingly, the actual results could differ significantly from those estimates.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p>
CY2023Q2 us-gaap Money Market Funds At Carrying Value
MoneyMarketFundsAtCarryingValue
269485746 usd
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Concentration of Credit Risk</b> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts and a Trust Account in a financial institution, which, at times, may exceed the Federal Deposit Insurance Corporation coverage of $250,000. Any loss incurred or a lack of access to such funds could have a significant adverse impact on the Company’s financial condition.</p>
us-gaap Insurance Commissions
InsuranceCommissions
250000 usd
CY2023Q2 us-gaap Business Acquisition Cost Of Acquired Entity Transaction Costs
BusinessAcquisitionCostOfAcquiredEntityTransactionCosts
17586741 usd
csta Noninterest Expense Offering Costs
NoninterestExpenseOfferingCosts
1143138 usd
CY2022 us-gaap Payment Of Financing And Stock Issuance Costs
PaymentOfFinancingAndStockIssuanceCosts
16443603 usd
CY2022 us-gaap Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
41110871 usd
CY2022Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
314517268 usd
CY2023Q1 csta Redemptions
Redemptions
269485746 usd
CY2023Q1 us-gaap Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
1819906 usd
CY2023Q1 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
46851428 usd
CY2023Q2 us-gaap Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
986515 usd
CY2023Q2 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
47837943 usd
csta Overallotment Option Expiration Date
OverallotmentOptionExpirationDate
2021-03-15
csta Trust Account
TrustAccount
10850000 usd
CY2023Q1 us-gaap Other Investments
OtherInvestments
3000000 usd
dei Entity Central Index Key
EntityCentralIndexKey
0001834032
CY2021Q1 csta Ordinary Shares Sold Units
OrdinarySharesSoldUnits
31000000 shares
CY2021Q1 us-gaap Sale Of Stock Price Per Share
SaleOfStockPricePerShare
10
CY2023Q2 us-gaap Warrants And Rights Outstanding Term
WarrantsAndRightsOutstandingTerm
P5Y
us-gaap Sale Of Stock Description Of Transaction
SaleOfStockDescriptionOfTransaction
In addition, if (x) the Company issues additional Class A ordinary shares or equity linked securities for capital raising purposes in connection with the closing of the initial Business Combination at an issue price or effective issue price of less than $9.20 per Class A ordinary share (with such issue price or effective issue price to be determined in good faith by the board of directors and, in the case of any such issuance to the initial shareholders or their affiliates, without taking into account any Founder Shares held by the initial shareholders or such affiliates, as applicable, prior to such issuance including any transfer or reissuance of such shares (the “Newly Issued Price”)), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest, available for the funding of the initial Business Combination, and (z) the volume-weighted average trading price of the Class A ordinary shares during the 10 trading day period starting on the trading day after the day on which the Company consummates the initial Business Combination is below $9.20 per share, the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of the Market Value and the Newly Issued Price, and the $10.00 and $18.00 per share redemption trigger prices adjacent to “Redemption of warrants for Class A ordinary shares when the price per Class A ordinary share equals or exceeds $10.00.” and “Redemption of warrants for Class A ordinary shares when the price per Class A ordinary share equals or exceeds $18.00.” will be adjusted (to the nearest cent) to be equal to 100% and 180% of the higher of the Market Value and the Newly Issued Price, respectively.
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
usd
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
usd
us-gaap Payments For Repurchase Of Other Equity
PaymentsForRepurchaseOfOtherEquity
usd
CY2023Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
shares
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
shares
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
shares
CY2023Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
shares
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
csta Redemption Of Warrants Description
RedemptionOfWarrantsDescription
Redemptions of warrants for cash when the price per Class A ordinary share equals or exceeds $10.00.Once the warrants become exercisable, the Company may call the warrants for redemption (except as described herein with respect to the Private Placement Warrants):   ● in whole and not in part;         ● at $0.10 per warrant upon a minimum of 30 days’ prior written notice of redemption; provided that during such 30 day period holders will be able to exercise their warrants on a cashless basis prior to redemption and receive that number of shares determined by reference to the table in the registration statement, based on the redemption date and the “fair market value” of the Class A ordinary shares (as defined below) except as otherwise described below; provided, further, that if the warrants are not exercised on a cashless basis or otherwise during such 30 day period, the Company shall redeem such warrants for $0.10 per share;         ● if, and only if, the Reference Value equals or exceeds $10.00 per share (as adjusted for share subdivisions, share dividends, reorganizations, recapitalizations and the like) on the trading day before the Company sends the notice of redemption to the warrant holders; and         ● if the Reference Value is less than $18.00 per share (as adjusted for share subdivisions, share dividends, reorganizations, recapitalizations and the like), the Private Placement Warrants must also be concurrently called for redemption on the same terms as the outstanding Public Warrants.
CY2022 csta Founder Shares
FounderShares
1125000 shares
CY2021Q1 us-gaap Stock Issued During Period Shares Share Based Compensation Forfeited
StockIssuedDuringPeriodSharesShareBasedCompensationForfeited
250000 shares
CY2021Q1 csta Founder Shares Forfeited
FounderSharesForfeited
875000 shares
csta Initial Business Combination
InitialBusinessCombination
P1Y
CY2020Q4 us-gaap Debt Instrument Unused Borrowing Capacity Amount
DebtInstrumentUnusedBorrowingCapacityAmount
1300 usd
CY2021Q1 csta Working Capital Loan
WorkingCapitalLoan
88540 usd
CY2021Q1 us-gaap Proceeds From Repayments Of Notes Payable
ProceedsFromRepaymentsOfNotesPayable
89840 usd
CY2021Q1 us-gaap Related Party Tax Expense Due To Affiliates Current
RelatedPartyTaxExpenseDueToAffiliatesCurrent
699999 usd
CY2022Q4 us-gaap Unsecured Debt
UnsecuredDebt
258780 usd
CY2023Q2 csta Outstanding Value
OutstandingValue
227208 usd
CY2022Q4 csta Outstanding Value
OutstandingValue
258780 usd
CY2021Q1 us-gaap Administrative Fees Expense
AdministrativeFeesExpense
10000 usd
CY2023Q2 us-gaap Payment For Administrative Fees
PaymentForAdministrativeFees
30000 usd
us-gaap Payment For Administrative Fees
PaymentForAdministrativeFees
60000 usd
CY2023Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
60000 usd
csta Working Capital Loans
WorkingCapitalLoans
1500000 usd
csta Class Of Warrant Or Right Exercise Price Of Warrants Or Rights
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights
1.5
CY2023Q1 us-gaap Related Party Tax Expense Due To Affiliates Current
RelatedPartyTaxExpenseDueToAffiliatesCurrent
230000 usd
CY2023Q1 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
1.5
CY2023Q1 us-gaap Temporary Equity Redemption Price Per Share
TemporaryEquityRedemptionPricePerShare
0.0001
CY2023Q2 us-gaap Deposits
Deposits
450000 usd
csta Loan Deposited Into The Trust Account
LoanDepositedIntoTheTrustAccount
150000 usd
CY2023Q1 csta Initial Principal Amount
InitialPrincipalAmount
450000 usd
CY2023Q1 csta Principal Amount
PrincipalAmount
1270000 usd
CY2023Q1 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
1.5
CY2023Q2 us-gaap Other Borrowings
OtherBorrowings
1865000 usd
CY2022Q4 us-gaap Other Borrowings
OtherBorrowings
0 usd
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
00000
CY2023Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2023Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
us-gaap Assets Fair Value Adjustment
AssetsFairValueAdjustment
606050 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
usd
CY2022Q4 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
usd
us-gaap Increase Decrease In Due To Related Parties Current
IncreaseDecreaseInDueToRelatedPartiesCurrent
usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
usd
us-gaap Payments To Invest In Decommissioning Fund
PaymentsToInvestInDecommissioningFund
usd
csta Cash Withdrawn From Trust Account In Connection With Redemption
CashWithdrawnFromTrustAccountInConnectionWithRedemption
usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
usd

Files In Submission

Name View Source Status
0001213900-23-067775-index-headers.html Edgar Link pending
0001213900-23-067775-index.html Edgar Link pending
0001213900-23-067775.txt Edgar Link pending
0001213900-23-067775-xbrl.zip Edgar Link pending
csta-20230630.xsd Edgar Link pending
f10q0623ex31-1_constella1.htm Edgar Link pending
f10q0623ex31-2_constella1.htm Edgar Link pending
f10q0623ex32-1_constella1.htm Edgar Link pending
f10q0623ex32-2_constella1.htm Edgar Link pending
f10q0623_constella1.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
csta-20230630_cal.xml Edgar Link unprocessable
csta-20230630_pre.xml Edgar Link unprocessable
csta-20230630_def.xml Edgar Link unprocessable
csta-20230630_lab.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
f10q0623_constella1_htm.xml Edgar Link completed
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending